Simultaneous Integrated Boost of intensity modulated radiation therapy to Stage II-III Non-Small Cell Lung Cancer with metastatic lymph nodes

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000029304

Enrollment

Unknown

Registered

2020-01-23

Start date

2009-10-01

Completion date

Unknown

Last updated

2020-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Small Cell Lung Cancer

Interventions

Case series:Simultaneous Integrated Boost of intensity modulated radiation therapy

Eligibility

Sex/Gender

All

Age

44 Years to 82 Years

Inclusion criteria

Inclusion criteria: (1) histologically or cytologically or PET-CT confirmed NSCLC; (2) newly diagnosed stage II-III disease (staged according to the 2009 system of the American Joint Committee on Cancer); (3) KPS >=70; (4) no contraindications to radiation therapy or chemotherapy; (5) Normal range of blood routine and biochemical indexes; (6) good compliance with treatment and follow-up.

Exclusion criteria

Exclusion criteria: (1) a history involving thoracic surgery, radiotherapy or chemotherapy; (2) pregnancy or lactation; (3) previous malignancy or other concomitant malignant disease.

Design outcomes

Primary

Measure	Time frame
primary tumor;metastatic lymph nodes;	—

Countries

China

Contacts

Public ContactBing Lu

Affiliated Hospital of Guizhou Medical University, and Guizhou Cancer Hospital

lbgymaaaa@163.com+86 13809432527

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026